| Literature DB >> 35431593 |
Never Zekeya1, Mariam Ibrahim2, Bertha Mamiro2, Humphrey Ndossi2, Mhuji Kilonzo3, Mwanaisha Mkangara4, Musa Chacha5, Jaffu Chilongola6, Jafari Kideghesho1.
Abstract
Chronic diseases including cardiovascular, diabetes and cancer persist for a long time in the course of treatment affecting health and are currently the cause of many deaths. In most cases, the treatment of chronic infectious diseases especially Tuberculosis relies on conventional drugs which are currently becoming fruitless due to drug resistance and unpredicted complications in course of treatment. However, herbal medicines have for a long time been used in prevention and treatment of chronic diseases including asthma and heart diseases in Africa. In this study, we extracted metabolites and screened for active compounds with potential free radical scavenging and pharmacological activities from Bersama abyssinica, the plant commonly used in traditional medicine in Tanzania. B. abyssinica root, stembark and leaf were air dried, sequentially extracted in various solvents including petroleum ether, dichloromethane, ethylacetate and methanol to yield extracts and fractions. The extracts and fractions were tested for the presence of several metabolites and antioxidant activity. The analysis of chemical compounds from resultant extracts was done by GC-MS for non-polar factions and LC-MS/MC for moderate polar extracts.High amount of phenolic acid, flavonoids and tannin were identified in ethylacetate fraction compared to ethanol, dichloromethane and petroleum ether. The GC-MS analysis of petroleum ether extract of B. abyssinica stem back yielded twelve (12) compounds with varying composition. The most abundant compounds were 2-Butenoic acid, 3-methyl-, ethyl ester comprising 33.8%, n-Hexadecanoic acid comprising 16.7% and Ethanolpentamethyl- yielded in 16.7%.The LC-MS/MS analysis of Ethyl acetate fractions yielded 20 compounds including; Mangiferin and Isoquercitin were abundant in leaves, stembark and roots. Lastly, ethyl vanillate was identified in both roots and leaves whereas Quercitrin and 7,8-Dimethoxycoumarin were found in stembark and root.These findings indicated that B. abyssinica is rich in phenolic compounds ranging from phenolic acids, flavonoids and coumarin that possess high antioxidant and pharmacological properties potential for treatment of chronic diseases.Entities:
Keywords: Antioxidant; Biological activities; Chronic diseases; Polyphenols; Winged bersama
Year: 2022 PMID: 35431593 PMCID: PMC9010792 DOI: 10.1016/j.sjbs.2022.03.023
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
The Percentage yields of leaf, stembark and root of B. abyssinica obtained from different extractor solvents.
| Stem bark (1000 g) | Petroleum ether | (1.7 g) 0.17% | (79.3 g) 7.93% |
| Dichloromethane | (3.8 g) 0.38% | ||
| Ethyl acetate | (3.7 g) 0.37% | ||
| Ethanol | (70.1 g) 7.01% | ||
| Root bark (1455 g) | Petroleum ether | (1.2 g) 0.082% | (88.8 g) 6.103% |
| Dichloromethane | (2.5 g) 0.171% | ||
| Ethyl acetate | (6.8 g) 0.467% | ||
| Ethanol | (78.3 g) 5.381% | ||
| Leaf (420 g) | Petroleum ether | (4.3 g) 1.023% | (28.9 g) 6.880% |
| Dichloromethane | (4.1 g) 0.976% | ||
| Ethyl acetate | (2.7 g) 0.642% | ||
| Ethanol | (17.8 g) 4.238% |
The scoring index of group of B. abyssinica secondary metabolites.
| Ratio | Percentage | |||||
|---|---|---|---|---|---|---|
| Root | Stem | Leaf | Root | Stembark | Leaf | |
| Petroleum ether | 1/5 | 4/5 | 0/5 | 20% | 80% | 0% |
| Dichloromethane | 1/5 | 2/5 | 1/5 | 20% | 40% | 20% |
| Ethyl acetate | 4/5 | 4/5 | 4/5 | 80% | 80% | 80% |
| Ethanol | 4/5 | 2/5 | 4/5 | 80% | 40% | 80% |
Qualitative results of Selected Group of Secondary metabolites present in B. abyssinica extracts and fractions.
| Tannin | Phenol | Flavonoid | Alkaloid | Saponin | Antioxidant | ||
|---|---|---|---|---|---|---|---|
| Petroleum ether | Stem bark | + | + | – | – | + | + |
| Root | – | – | – | – | – | + | |
| Leaf | – | – | – | – | – | + | |
| Dichloromethane | Stem bark | + | – | – | – | – | + |
| Root | – | – | – | – | – | + | |
| Leaf | – | – | – | – | – | + | |
| Ethyl acetate | Stem bark | + | + | + | – | + | + |
| Root | + | + | + | – | + | + | |
| Leaf | + | + | + | – | + | + | |
| Ethanol | Stem bark | + | + | + | – | – | + |
| Root | + | + | – | – | – | + | |
| Leaf | + | + | + | – | + | + | |
Key: + = indicates presence of secondary metabolites and - = indicates absence of secondary metabolites.
GC–MS analysis of B. abyssinica stem bark petroleum ether fraction constituents.
| 1 | 2-Butenoic acid, 3-methyl-, ethyl ester | 33.869 | 10.013 | 83.1 | 423,679 |
| 2 | Ethanol, pentamethyl- | 14.633 | 11.287 | 59.05 | 240,839 |
| 3 | Dodecanoic acid | 1.396 | 21.072 | 60.05 | 30,905 |
| 4 | Tetradecanoic acid | 1.061 | 25.351 | 60.05 | 29,604 |
| 5 | Perhydrofarnesyl acetone | 1.476 | 26.849 | 58.05 | 19,670 |
| 6 | n-Hexadecanoic acid | 16.758 | 29.385 | 60.05 | 447,724 |
| 7 | Eicosanoic acid, ethyl ester | 7.193 | 29.773 | 88.1 | 86,325 |
| 8 | 9-Octadecegnoic acid, (E)- | 6.181 | 32.519 | 55.05 | 99,919 |
| 9 | Oleic Acid | 5.038 | 32.47 | 55.05 | 101,281 |
| 10 | 9-Octadecenoic acid, (E)- | 6.181 | 32.519 | 55.05 | 99,919 |
| 11 | Eicosanoic acid | 3.360 | 32.924 | 57.1 | 41,094 |
| 12 | 4,8,12,16-Tetramethylheptadecan-4-olide | 2.854 | 35.967 | 99.1 | 39,122 |
Analysis of B. abyssinica Petroleum ether extract compounds and biological activities.
| 1 | 2-Butenoic acid, 3-methyl-, ethyl ester | Fatty acid | Aroma in breweries | ( |
| 2 | Ethanol, pentamethyl- | Alcohol | Pyrolysis | ( |
| 3 | Dodecanoic acid | Fatty acid | Potential compound for energy production | ( |
| 4 | Tetradecanoic acid | Fatty acid | Larvicidal and Repellent activities | ( |
| 5 | Perhydrofarnesyl acetone | Terpenes | ||
| 6 | n-Hexadecanoic acid | Fatty acid | Antiiflamatory and antirheumatism | ( |
| 7 | Eicosanoic acid, ethyl ester | Fatty acid | Antimicrobial activity | ( |
| 8 | 9-Octadecenoic acid, (E)- | Fatty acid | Antimicrobial activity | ( |
| 9 | Oleic Acid | Lubricant | ( | |
| 10 | 9-Octadecenoic acid, (E)- | Fatty acid | Quenching and anti-biofilm | ( |
| 11 | Eicosanoic acid | Fatty acid | Antiurease and antioxidant | ( |
| 12 | 4,8,12,16-Tetramethylheptadecan-4-olide | Fatty acid | Antimicrobial activity | ( |
LC-MS/MS Analysis of ethyl acetate fractions of constituents.
| SN | Mass to Charge Ratio( | Fractions codes and names of compounds eluted | ||
|---|---|---|---|---|
| BAREt | BASEt | BALEt | ||
| 1 | 422.08491 | Mangiferin | Mangiferin | Mangiferin |
| 2 | 196.073559 | Ethyl Vanillate | – | Ethyl Vanillate |
| 3 | 328.094688 | – | 3-Hydroxy-7,2,3-trimethoxyflavone | – |
| 4 | 448.100561 | Quercitrin | Quercitrin | – |
| 5 | 250.047738 | – | – | 7,8-Dihydroxy-4-methylcoumarin-3-acetic acid |
| 6 | 245.105193 | 7-Diethylamino-3-formycoumarin | – | – |
| 7 | 210.125594 | – | -g | Jasmonic acid |
| 8 | 182.057909 | – | Syringaldehyde | – |
| 9 | 464.095476 | Isoquercitin | Isoquercitin | Isoquercitin |
| 10 | 167.021857 | Dipicolinic acid | – | – |
| 11 | 216.078644 | O-Desmethylnaproxen | – | – |
| 12 | 312.099773 | – | 5,7,4-Trimethoxyisoflavone | – |
| 13 | 206.057909 | 7,8-Dimethoxycoumarin | 7,8-Dimethoxycoumarin | – |
| 14 | 158.084398 | – | – | 1,4-Diaminonaphthalene |
| 15 | 342.110338 | 5,7,3,4-Tetramethoxyisoflavone | – | – |
| 16 | 328.094688 | – | – | 3-Hydroxy-6,3,4-trimethoxyflavone |
| 17 | 253.107594 | Triamterene | – | – |
| 18 | 161.105193 | – | – | L-Carnitine |
| 19 | 282.089209 | 6,7-Dimethoxyisoflavone | – | – |
| 20 | 262.012209 | 3,4-Dimethoxy-5,7,3-trihydroxyflavone | – | – |
Key: -Not detected.
BaSP = Bersamaabysinica Stem petroleum ether, BaSEt = Bersama abysinica stembark ethyl acetate, BaLP = Bersama abysinica leaves petroleum ether, BaLEt = Bersama abysinica leaves ethyl acetate, BaRP = Bersamaabysinicarootpetroleum ether and BaREt = Bersamaabysinica root ethyl acetate.
Analysis of B. abyssinica Ethylacetate fractionsand their biological activities.
| S/ | ||||
|---|---|---|---|---|
| 1 | Mangiferin | Phenol | Anti-oxidant, antitumor, antidiabetic, Anti-inflammation, anti- viral (HIV), Enhancing immune response, treatment of liver | ( |
| 2 | Ethyl Vanillate | Phenol | Antimicrobial(histoplasmosis) | ( |
| 3 | 3-Hydroxy-7,2,3-trimethoxyflavone | Flavonoid | Antioxidant | ( |
| 4 | Quercitrin | Flavonoid | Antioxidant, anti-inflammatory, antiviral Immune modulatory activities | ( |
| 5 | 7,8-Dihydroxy-4-methylcoumarin-3-acetic acid | Coumarin | Anticancer, protect against leukemia | ( |
| 6 | 7-Diethylamino-3-formycoumarin | Coumarin | Not known | – |
| 7 | Jasmonic acid | Acetic acid | anti-cancer, anti-inflammatory | ( |
| 8 | Syringaldehyde | Phenol | Antihyperglycemic, antimicrobial | ( |
| 9 | Isoquercitin | Flavonoid | Antiviral, antioxidant, anticardiovascular | ( |
| 10 | Dipicolinic acid | Acid | Mediate the resistance of Metallo- β-lactamase bacteria | ( |
| 11 | O-Desmethylnap | Acid | Anti-inflammatory | ( |
| 12 | 5,7,4Trimethoxyisoflavone | Flavonoid | Intermediate for drug synthesis | ( |
| 13 | 7,8Dimethoxycoumarin | Coumarin | Antioxidant, anticancer, anti-inflammatory | ( |
| 14 | 1,4Diaminonaphthalene | Protein | Anti-inflamatory | ( |
| 15 | 5,7,3,4Tetramethoxyisoflavone | Flavonoid | Antimicrobial activity | ( |
| 16 | 3-Hydroxy-6,3,4-trimethoxyflavone | Flavonoid | Antimicrobial | ( |
| 17 | Triamterene | Phenol | potassium-sparing diuretic, Lowering hypertension | ( |
| 18 | L-Carnitine | Protein | Treatment of kidney and insulin | ( |
| 19 | 6,7-Dimethoxyisoflavone | Flavonoid | Anticancer | ( |
| 20 | 3,4-Dimethoxy-5,7,3-trihydroxyflavone | Flavonoid | Inhibit human colon cancer | ( |